Appalachia-the region from Mississippi to New York-faces historic health, social, and economic disparities compared with the rest of the United States. Infant mortality and life expectancy rates in this region are expected to remain substantially worse until there are changes in the certain inequalities, including education, poverty, housing, and labor market opportunities, according to researchers.
Appalachia—the region from Mississippi to New York—faces historic health, social, and economic disparities compared with the rest of the United States. Infant mortality and life expectancy rates in this region are expected to remain substantially worse until there are changes in the certain inequalities, including education, poverty, housing, and labor market opportunities, according to researchers.
A study published by Health Affairs compared infant mortality and life expectancy disparities in Appalachia to those in outside regions from 1990 to 2013. The Appalachia region, as defined by the 2008 Appalachian Regional Commission, covers 428 counties among 13 states. Researchers collected the infant mortality rates and life expectancy at birth 7 times during the period and collected the participants’ demographics, including poverty levels.
The researchers found that the population in Appalachia grew by 16% during the study period, while the rest of the United States grew by 25%. Furthermore, the socioeconomic status is also lower in Appalachia, with higher poverty, lower rates of physician availability with a greater need for healthcare services.
From 2009 to 2013, the infant mortality rate was 16% higher in Appalachia than the rest of the United States with an even greater disparity among black infants. High-poverty levels further affected this rate, as infant mortality rates in 2009 to 2013 were 39% greater than low-poverty areas.
The Appalachia region’s life expectancy from 1990 to 1992 was 75.2 years—0.6 years shorter than the rest of the United States; however, from 2009 to 2013, this deficit increased to 2.4 years. The association between poverty level and life expectancy was more apparent in Appalachia than the rest of the United States, as those in high-poverty areas had a life expectancy of 75.1 years, while those in low-poverty areas were likely to live to 79.9 years old.
“It should be noted that with social and economic inequality continuing to increase and rates of obesity and related chronic conditions rising, there is no guarantee that life expectancy and mortality rates will continue to improve in the United States and its regions, including Appalachia,” the researchers wrote.
The study suggested that in order to reduce the gap among certain US regions there needs to be policy changes at various government levels that promote increased access to high-quality affordable health care. Such policies and education measures could assist in decreasing the high mortality rates from cardiovascular diseases, lung cancer, chronic lower respiratory diseases or chronic obstructive pulmonary disease, diabetes, nephritis or kidney diseases, suicide, unintentional injuries, and drug overdoses.
“Disparities between Appalachia and the rest of the United States in infant mortality and life expectancy are expected to remain substantial for the foreseeable future, given that differences in mortality from several major causes of death are persisting or even increasing,” the study concluded. “Health policy interventions such as smoking reduction, anti-obesity measures, and improved access to healthcare have the potential to reduce health disparities between Appalachia and the rest of the country.”
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More